Device / Technology News

RSS

FlexStent Femoropopliteal SE Stent System FIM study results presented at VIVA conference

Final first-in-man (FIM) clinical results on the use of the FlexStent® Femoropopliteal SE Stent System were presented recently at the VIVA conference in Las Vegas by Dr. Andrew Holden of Auckland City Hospital. The clinical results originated from Flexible Stenting Solutions, Inc.'s (FSS) FIM study conducted in New Zealand by Principle Investigator Dr. Andrew Holden, and FSS's supplementary study conducted in Germany by Principle Investigator Dr. Dierk Scheinert of University of Leipzig - Heart Center.

10 Nov 2010

Iris BioTechnologies awarded $245,000 grant under QTDP Program

Iris BioTechnologies Inc., a life sciences company focused on providing patients, doctors, and clinicians with improved methods of identifying effective treatment solutions, and recipient of the Frost and Sullivan 2008 Technology Innovation Award in Pharmacogenomics, is pleased to announce that the company has been awarded $245,000, the maximum amount given for a grant under the US Qualifying Therapeutic Discovery Project (QTDP) Program.

10 Nov 2010

Undergraduate students win Gates Foundation grant for low-cost ultrasound system

A team of University of Washington undergraduate students was among 65 research groups that today learned they had won one of the Bill & Melinda Gates Foundation's $100,000 Grand Challenges Explorations grants.

10 Nov 2010

BSD Medical awarded two grants under QTDP Program

BSD Medical Corporation announced today that it has received the maximum award provided by the U.S. government for a single program for two separate grants under the Qualifying Therapeutic Discovery Project ("QTDP") Program.

10 Nov 2010

Biovista and Pfizer enter pilot research collaboration

Biovista announced today that it has entered into a pilot research collaboration agreement with Pfizer. The aim of the collaboration is to identify new indications for a number of undisclosed Pfizer development candidates, using Biovista's Clinical Outcome Search Space (COSS) technology.

10 Nov 2010

Boston Scientific announces first implantation of Vercise Deep Brain Stimulation System in Parkinson's disease trial

Boston Scientific Corporation today announced the first implantation of its Vercise™ Deep Brain Stimulation (DBS) System as part of the VANTAGE clinical trial. VANTAGE is a multi-center, prospective trial designed to examine the improvement of motor function in approximately 40 European patients implanted with the Vercise DBS System for the treatment of Parkinson's disease.

10 Nov 2010

CRi adds TRIO to Nuance multispectral imaging product family

Cambridge Research & Instrumentation, Inc. (CRi), a leader in multicolor imaging solutions for preclinical and clinical research, today announced the newest addition to the award-winning Nuance™ multispectral imaging product family for multicolor tissue and cell-based imaging. The TRIO system is compact, multipurpose and affordable, offering a simplified interface and versatile design to fit any microscope with a camera-mount.

10 Nov 2010

Gov't health IT spending attracts investments from all over

As part of its foray into health IT, AT&T has partnered with WellDoc, a Baltimore-based company that makes an FDA-approved mobile-phone application to help manage diabetes, The Baltimore Sun reports. "The telecommunications giant launched a new business segment last week that will focus on technology solutions for the health care industry. And WellDoc's software will be pitched by AT&T's huge marketing muscle to commercial clients ranging from hospitals to insurers to employers" (Sentementes, 11/8).

10 Nov 2010

Baxa launches ExactaMix 1200 Automated Compounding Device

Baxa Corporation, a leading provider of medical devices and systems that automate pharmacy operations, today introduced the ExactaMix 1200 Automated Compounding Device (ACD) for small- to mid-sized hospital pharmacies in need of an automated approach to compounding large-volume parenteral doses.

9 Nov 2010

Health advice on NHS website saves £44 million per year

The latest study has shown that as more people self diagnose using the NHS Choices website, Britain’s national healthcare service saves millions of pounds every year. The website was launched three years ago. Last year more than 100 million visits were recorded at the site which offers patients a quick reference guide to illnesses, symptoms, diagnosis and treatment. Overall, there was a 10% increase in the number of visits to the website in 2010 compared to 2009. Some 19 million people logged on to NHS Choices for information on swine flu.

9 Nov 2010

Changes in Medicare policies may hamper supply of power wheelchairs

Will power wheelchairs continue to be available to Nevada's Medicare patients following a series of federal regulatory and policy changes?

9 Nov 2010

Patients with germinal center-like structures face greater risk of developing non-Hodgkin's lymphoma

Biopsying the glands that produce saliva to test for germinal center-like formation when someone is diagnosed with primary Sjögren's Syndrome can predict later development of non-Hodgkin's lymphoma, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Atlanta.

9 Nov 2010

Data breaches of patient information cost healthcare organizations $6 billion annually

The latest benchmark study by Ponemon Institute, sponsored by ID Experts®, finds that data breaches of patient information cost healthcare organizations nearly $6 billion annually, and that many breaches go undetected. The research indicates that protecting patient data is a low priority for hospitals and that organizations have little confidence in their ability to secure patient records, putting individuals at great risk for medical identity theft, financial theft and embarrassment of exposure of private information.

9 Nov 2010

Spectral Molecular Imaging awarded $190,172 QTDP grant for development of melanoma detection system

Cascade Technologies Corp., announced today that its wholly-owned subsidiary Spectral Molecular Imaging, Inc. (SMI) has received a grant under the Qualifying Therapeutic Discovery Project (QTDP) program to advance the development of the company's SkinSpect system for the detection of melanoma and other skin cancers.

9 Nov 2010

Research report on current and evolving technologies in drug delivery

The drug delivery market is a rapidly evolving force in the pharmaceutical industry. Within this segment injectables have a significant role to play at present with the increasing use of proteins and peptides.

9 Nov 2010

Researchers use near-infrared spectroscopy to study facial expressions in infants

Japanese research group led by Prof. Ryusuke Kakigi and Dr. Emi Nakato (National Institute for Physiological Sciences: NIPS) and Prof. Masami K Yamaguchi (Chuo University) found that the hemispheric differences in the temporal area overlying superior temporal sulcus (STS) when processing positive (happy) and negative (angry) facial expressions in infants.

9 Nov 2010

Patented cover for stethoscopes will curb hospital-acquired infections

Saints Medical Center is pleased to announce that Richard H. Ma, M.D, chair of its hospitalist department, has received a patent for a lightweight plastic cover for stethoscopes that will dramatically reduce hospital-acquired infections.

9 Nov 2010

Food insecurity may cause problem for diabetic patients living on fixed incomes

The economic recession impacts many aspects of our lives including an increase incidence of food insecurity. This can have serious consequences for those suffering from chronic illnesses like diabetes.

9 Nov 2010

NEW ANA testing does not diagnose disorder in 40% of scleroderma patients

New research from Georgetown University Medical Center (GUMC) suggests that up to 40 percent of scleroderma patients will not be correctly diagnosed with the disorder using a new automated commercial screening test. The findings of the study will be presented Wednesday, November 10th at the Annual Scientific Meeting of the American College of Rheumatology in Atlanta, Georgia.

9 Nov 2010

Exempla Healthcare selects ProVation MD for streamlined procedure documentation and coding

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Exempla Healthcare has selected its ProVation® MD software for gastroenterology and pulmonary procedure documentation and coding. ProVation MD will be deployed across three hospitals in the nationally recognized Exempla Healthcare System.

9 Nov 2010

Device / Technology News

FlexStent Femoropopliteal SE Stent System FIM study results presented at VIVA conference

Iris BioTechnologies awarded $245,000 grant under QTDP Program

Undergraduate students win Gates Foundation grant for low-cost ultrasound system

BSD Medical awarded two grants under QTDP Program

Biovista and Pfizer enter pilot research collaboration

Boston Scientific announces first implantation of Vercise Deep Brain Stimulation System in Parkinson's disease trial

CRi adds TRIO to Nuance multispectral imaging product family

Gov't health IT spending attracts investments from all over

Baxa launches ExactaMix 1200 Automated Compounding Device

Health advice on NHS website saves £44 million per year

Changes in Medicare policies may hamper supply of power wheelchairs

Patients with germinal center-like structures face greater risk of developing non-Hodgkin's lymphoma

Data breaches of patient information cost healthcare organizations $6 billion annually

Spectral Molecular Imaging awarded $190,172 QTDP grant for development of melanoma detection system

Research report on current and evolving technologies in drug delivery

Researchers use near-infrared spectroscopy to study facial expressions in infants

Patented cover for stethoscopes will curb hospital-acquired infections

Food insecurity may cause problem for diabetic patients living on fixed incomes

NEW ANA testing does not diagnose disorder in 40% of scleroderma patients

Exempla Healthcare selects ProVation MD for streamlined procedure documentation and coding

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Latest News